Home › Funds › Voss Capital, LP › ACTU

Voss Capital, LP position in ACTU

ACTUATE THERAPEUTICS INC · Health Care

Voss Capital, LP reported holding 1,725,000 shares of ACTU (ACTUATE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.18% of its reported portfolio and ranking #38 among its reported holdings. Voss Capital, LP has disclosed ACTU holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)1.73M sh
Reported value held$2.64M
Portfolio Weight0.18%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Voss Capital, LP's ACTU position evolved

Voss Capital, LP first disclosed a stake in ACTU in Q4 2024 at 55,246 shares (US$440K). The position peaked in Q4 2025 at 1,300,000 shares, worth US$8.0M. Across 7 filings, Voss Capital, LP increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,725,000 shares valued at US$2.6M. Notable position changes include a 158% increase in Q1 2025 (shares fell 10% over the following quarter), a 101% increase in Q2 2025 (shares rose 9% over the following quarter), a 213% increase in Q3 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 55.25K $439.76K New
Q1 2025 142.38K $963.92K Add
Q2 2025 286.14K $1.75M Add
Q3 2025 896.28K $6.00M Add
Q4 2025 1.30M $7.96M Add
Q1 2026 1.73M $4.73M Add
Q2 2026 1.73M $2.64M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACTU and 13F data

ACTU (ACTUATE THERAPEUTICS INC) is a Health Care company. 60 other funds we track also report a position in ACTU — the largest reported positions include BIOS Capital Management, LP (US$15.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACTU

All ACTU fund holders →

FAQ

How long has Voss Capital, LP held ACTU?

Voss Capital, LP has disclosed ACTU holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Voss Capital, LP's current position in ACTU?

As of Q2 2026, Voss Capital, LP holds 1.73M shares of ACTU (ACTUATE THERAPEUTICS INC), valued at $2.64M, representing 0.18% of its reported portfolio and ranking #38.

Has Voss Capital, LP been buying or selling ACTU?

In the latest 13F filing (Q2 2026), Voss Capital, LP held unchanged its position in ACTU. The position peaked in Q4 2025 at 1.30M shares.

Which other funds hold ACTU?

Other major institutional holders of ACTU include BIOS Capital Management, LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.